Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists

被引：76

作者：

Palani, Anandan ^{[1
]}

Tagat, Jayaram R. ^{[1
]}

机构：

[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 10期

关键词：

D O I：

10.1021/jm060009x

中图分类号：

R914 [药物化学];

学科分类号：

100701 [药物化学];

摘要：

引用

页码：2851 / 2857

页数：7

共 61 条

[1]

Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells [J].

Ajuebor, MN ;

Aspinall, AI ;

Zhou, F ;

Le, T ;

Yang, Y ;

Urbanski, SJ ;

Sidobre, W ;

Kronenberg, M ;

Hogaboam, CM ;

Swain, MG .

JOURNAL OF IMMUNOLOGY, 2005, 174 (12) :8027-8037

[2]

Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2 [J].

Ank, N ;

Petersen, YJ ;

Malmgaard, L ;

Mogensen, SC ;

Paludan, SR .

JOURNAL OF VIROLOGY, 2005, 79 (15) :9831-9841

[3]

Anonymous, 2005, Antiviral Chemistry & Chemotherapy, V16, P339

[4]

TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans [J].

Baba, M ;

Takashima, K ;

Miyake, H ;

Kanzaki, N ;

Teshima, K ;

Wang, X ;

Shiraishi, M ;

Iizawa, Y .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4584-4591

[5]

Highly active antiretroviral therapy: Current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome [J].

Barbaro, G ;

Scozzafava, A ;

Mastrolorenzo, A ;

Supuran, CT .

CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) :1805-1843

[6]

Barber Chris G, 2004, Curr Opin Investig Drugs, V5, P851

[7]

Barr Erika L., 2005, Journal of Microbiology Immunology and Infection, V38, P244

[8]

Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].

Berger, EA ;

Murphy, PM ;

Farber, JM .

ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700

[9]

Toxicity of antiretroviral therapy and implications for drug development [J].

Carr, A .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (08) :624-634

[10]

Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity [J].

Clader, JW ;

Billard, W ;

Binch, H ;

Chen, LY ;

Crosby, G ;

Duffy, RA ;

Ford, J ;

Kozlowski, JA ;

Lachowicz, JE ;

Li, SJ ;

Liu, C ;

McCombie, SW ;

Vice, S ;

Zhou, GW ;

Greenlee, WJ .

BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (02) :319-326

← 1 2 3 4 5 6 7 →